AC Immune S.A. (ACIU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 34,662 | 31,180 | 22,204 | 41,205 | 37,458 |
| Marketable Securities | 100,868 | 122,933 | 139,778 | 146,774 | 144,990 |
| Receivables | 1,977 | 1,965 | 2,212 | 1,254 | 29,429 |
| Other current assets | 502 | 618 | 1,029 | 1,248 | 901 |
| TOTAL | $142,126 | $159,778 | $169,234 | $195,368 | $216,760 |
| Non-Current Assets | |||||
| PPE Net | 2,759 | 3,018 | 3,071 | 3,011 | 3,161 |
| Investments And Advances | 730 | 708 | 651 | 471 | 480 |
| Intangibles | 62,995 | 61,114 | 56,083 | 57,268 | 58,256 |
| Other Non-Current Assets | 5,814 | 5,971 | 5,769 | 6,176 | 3,572 |
| TOTAL | $72,297 | $70,812 | $65,574 | $66,926 | $65,468 |
| Total Assets | $214,423 | $230,590 | $234,808 | $262,294 | $282,229 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,957 | 3,308 | 2,660 | 3,019 | 1,636 |
| Accrued Expenses | 14,985 | 13,911 | 12,399 | 13,742 | 14,905 |
| TOTAL | $122,808 | $119,970 | $110,401 | $114,542 | $116,691 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 104,561 | 101,491 | 94,194 | 96,615 | 99,348 |
| Other Non-Current Liabilities | 10,217 | 15,657 | 14,552 | 15,045 | 9,598 |
| TOTAL | $13,591 | $20,016 | $18,953 | $20,225 | $15,132 |
| Total Liabilities | $136,399 | $139,986 | $129,354 | $134,767 | $131,823 |
| Shareholders' Equity | |||||
| Common Shares | 2,799 | 2,711 | 2,481 | 2,529 | 2,563 |
| Retained earnings | -524,479 | -493,316 | -429,622 | -418,283 | -403,197 |
| Other shareholders' equity | -269 | -259 | -244 | -253 | -280 |
| TOTAL | $78,024 | $90,604 | $105,453 | $127,528 | $150,406 |
| Total Liabilities And Equity | $214,423 | $230,590 | $234,808 | $262,294 | $282,229 |